Dr Aqua Asif
Urologist
Dr Asif is a doctor in urology with a strong research track record.
She will join UCL/UCLH as an NIHR Academic Clinical Fellow in 2025.
Her work targets better prostate MRI quality and access across health systems.
She contributes to trials improving scan quality and patient pathways.
She is active in medical education and curriculum development
Education and qualifications
Awards and highlights
- British Association of Urological Surgeons.
- BAUS Section of Oncology.
- Royal College of Surgeons of England.
- British Medical Association.
Awards and highlights
- Royal Surrey news feature on PRIME/GLIMPSE and MRI quality impact.
- EAU 2023 Best Abstract by Resident (GLIMPSE team).
- Royal Surrey Clinical Audit Day — First Prize (2023).
At a glance
- Current: NIHR Academic Clinical Fellow (Urology), UCL / UCLH (from Oct 2025).
- Honorary roles: UCL Division of Surgery & Interventional Science.
- Previous: Royal Surrey NHS Foundation Trust, research and education.
- Degrees: MBChB (Leicester, 2017).
- Memberships/awards: MRCS (2024), FHEA, MAcadMEd.
- Research focus: Prostate MRI quality and access; urology education.
Expertise
Profiles and links
- MBChB, University of Leicester (2017).
- MRCS, Royal College of Surgeons of England (2024).
- BSc, PGCert (medical education focus).
- FHEA, MAcadMEd.
Profiles and links
- ResearchGate: researchgate.net/profile/Aqua-Asif
- ASiT elected member page: asit.org › Elected Members
- Royal Surrey news: royalsurrey.nhs.uk › News
- ORCID/Scholar profiles if available.
Research and publications
- Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME) — Trial Protocol. BMJ Open. 2023. https://doi.org/10.1136/bmjopen-2022-070280
- Global variation in MRI quality of the prostate: PRIME quality control phase using PI-QUAL. Radiology. 2023. Royal Surrey summary confirms scale and impact.
- The LANDMARK project: summaries of key papers shaping urology. BJU International. 2024. https://doi.org/10.1111/bju.16548
- PRIME Diagnostic Clinical Trial: Biparametric vs Multiparametric MRI. JAMA. 2025. Forthcoming / early view on ResearchGate.
- Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial. JAMA. 2025. https://doi.org/10.1001/jama.2025.13722
- VISION: An Individual Patient Data Meta-analysis of Randomised Trials Comparing MRI-targeted Biopsy with Standard TRUS-guided Biopsy in Prostate Cancer Detection. European Urology. 2024. https://doi.org/10.1016/j.eururo.2024.08.022
- Global Variation in Magnetic Resonance Imaging Quality of the Prostate. Radiology. 2023. https://doi.org/10.1148/radiol.231130
- AI decision support for increasing prostate biopsy efficiency: a retrospective multicentre, multiscanner study. European Radiology. 2026. https://doi.org/10.1007/s00330-026-12361-6
- Decision Regret in Patients with Localised Prostate Cancer: A Systematic Review and Meta-analysis. European Urology Oncology. 2023. https://doi.org/10.1016/j.euo.2023.02.005
- RESECT: A Randomised Controlled Trial of Audit and Feedback in Non-muscle-invasive Bladder Cancer Surgery. European Urology. 2025. https://doi.org/10.1016/j.eururo.2025.09.4174
- Introducing WASHOUT: A Large-scale Observational Study of Inpatient Haematuria. European Urology Focus. 2024. https://doi.org/10.1016/j.euf.2024.01.014
- Ultrasound for the Diagnosis of Testicular Torsion: A Systematic Review and Meta-analysis of Diagnostic Accuracy. European Urology Focus. 2025. https://doi.org/10.1016/j.euf.2025.04.026
Learn more about Focal Therapy and Prostate Cancer
Survey of Prostate Cancer Patients Reveals Severe Knowledge Gaps Among Men
Length: 6 min read Key Takeaways A survey of 243 prostate cancer patients revealed major...
How Accurate is a Urine test for Prostate Cancer – and can it replace PSA or MRI?
Author: The Focal Therapy Clinic Length: 8 min read Published: 14 May 2026 Medically Reviewed:...
Is Testosterone Replacement Therapy Safe After Prostate Cancer Treatment?
Author: The Focal Therapy Clinic Length: 8 min read Published: 14 May 2026 Medically Reviewed:...
Any questions?
If you’ve got any questions about your prostate cancer diagnosis or want to know more about HIFU or NanoKnife, don’t hesitate to get in touch with our friendly, knowledgeable team.
Contact the team
Subscribe to our newsletter
Get expert advice & the latest prostate cancer research - straight to your inbox.
We care about your data in our privacy policy.
